Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Artelo Biosciences stock | $1.02

Own Artelo Biosciences stock in just a few minutes.

Fact checked

Artelo Biosciences, Inc is a biotechnology business based in the US. Artelo Biosciences shares (ARTL) are listed on the NASDAQ and all prices are listed in US Dollars. Artelo Biosciences employs 3 staff and has a market cap (total outstanding shares value) of USD$9.7 million.

How to buy shares in Artelo Biosciences

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Artelo Biosciences. Find the stock by name or ticker symbol: ARTL. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Artelo Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.02, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Artelo Biosciences, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Artelo Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Artelo Biosciences share price

Use our graph to track the performance of ARTL stocks over time.

Artelo Biosciences shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$1.02
52-week rangeUSD$0.451 - USD$3.08
50-day moving average USD$0.5962
200-day moving average USD$0.9019
Wall St. target priceUSD$8
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.082

Buy Artelo Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Artelo Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Artelo Biosciences price performance over time

Historical closes compared with the close of $1.02 from 2021-01-11

1 week (2021-01-07) 2.00%
1 month (2020-12-15) 55.25%
3 months (2020-10-15) 56.20%
6 months (2020-07-15) -5.56%
1 year (2020-01-15) -56.13%
2 years (2019-01-15) -11.30%
3 years (2018-01-13) N/A
5 years (2016-01-13) N/A

Artelo Biosciences financials

Gross profit TTM USD$0
Return on assets TTM -53.94%
Return on equity TTM -99.72%
Profit margin 0%
Book value $0.776
Market capitalisation USD$9.7 million

TTM: trailing 12 months

Shorting Artelo Biosciences shares

There are currently 592,848 Artelo Biosciences shares held short by investors – that's known as Artelo Biosciences's "short interest". This figure is 3.1% up from 575,184 last month.

There are a few different ways that this level of interest in shorting Artelo Biosciences shares can be evaluated.

Artelo Biosciences's "short interest ratio" (SIR)

Artelo Biosciences's "short interest ratio" (SIR) is the quantity of Artelo Biosciences shares currently shorted divided by the average quantity of Artelo Biosciences shares traded daily (recently around 3.1 million). Artelo Biosciences's SIR currently stands at 0.19. In other words for every 100,000 Artelo Biosciences shares traded daily on the market, roughly 190 shares are currently held short.

However Artelo Biosciences's short interest can also be evaluated against the total number of Artelo Biosciences shares, or, against the total number of tradable Artelo Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Artelo Biosciences's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Artelo Biosciences shares in existence, roughly 40 shares are currently held short) or 0.0402% of the tradable shares (for every 100,000 tradable Artelo Biosciences shares, roughly 40 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Artelo Biosciences.

Find out more about how you can short Artelo Biosciences stock.

Artelo Biosciences share dividends

We're not expecting Artelo Biosciences to pay a dividend over the next 12 months.

Artelo Biosciences share price volatility

Over the last 12 months, Artelo Biosciences's shares have ranged in value from as little as $0.451 up to $3.08. A popular way to gauge a stock's volatility is its "beta".

ARTL.US volatility(beta: 1.42)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Artelo Biosciences's is 1.422. This would suggest that Artelo Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Artelo Biosciences overview

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1 clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is headquartered in La Jolla, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site